Clinical InvestigationPediatricsHospital readmissions in children with congenital heart disease: A population-based study
Section snippets
Setting and data sources
This is a population-based study using administrative data from the province of Quebec, Canada, where universal access to health care is provided. A unique health care number is assigned at birth and is systematically linked to all health-related services. The database of the Régie de l'Assurance Maladie du Québec records physician claims, and the hospital discharge database (Med-Echo) records information related to inpatient care. Together, these databases contain demographic information in
Results
There were 4085 hospitalizations that met inclusion criteria over the 15-year period. Of these, hospitalizations were excluded if they were for a day procedure or <1 day in duration (n = 355) or because of death during the index hospitalization (n = 55). The remaining 3675 hospitalizations (among 3675 children) form the study population for analysis, of which 1768 children (48%) were female and 1451 (39%) had severe CHD.
After the 3675 hospitalizations, there were 180 readmissions (5%) within 7
Discussion
In a publicly funded health care system with universal access to care, we found that hospital readmission within 1 month was common, occurring in approximately 1 in 9 children and 1 in 5 infants. The most common problems prompting readmission were cardiac or respiratory illnesses, followed by complications. Children with severe CHD lesions were more likely to be readmitted, as were infants, those who had visited an emergency department in the preceding 6 months, had more complex index
References (18)
- et al.
Health care resource utilization in adults with congenital heart disease
Am J Cardiol
(2007) - et al.
Risk factors for readmission after neonatal cardiac surgery
Ann Thorac Surg
(2004) - et al.
Ultra fast track in elective congenital cardiac surgery
Ann Thorac Surg
(2000) - et al.
Congenital heart disease in the general population: changing prevalence and age distribution
Circulation
(2007) - et al.
A pilot study of expenditures on, and utilization of resources in, health care in adults with congenital heart disease
Cardiol Young
(2001) - et al.
Risk factors for readmission to hospital for asthma in childhood
Thorax
(1994) - et al.
Trends in hospital readmission for asthma: has the Australian National Asthma Campaign had an effect?
Med J Aust
(2000) - et al.
Increased neonatal readmission rate associated with decreased length of hospital stay at birth in Canada
Can J Public Health
(2000) Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 9th Revision
(1977)
Cited by (67)
A Narrative Review of Multiinstitutional Data Registries of Pediatric Congenital Heart Disease in Pediatric Cardiac Anesthesia and Critical Care Medicine
2023, Journal of Cardiothoracic and Vascular AnesthesiaCitation Excerpt :The treatment of patients with CHD consumes significant medical resources and billions of dollars annually in hospital and physician expenses, yet limited funded research has been conducted in pediatric cardiac disease.9-13
Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults With Congenital Heart Disease
2022, Canadian Journal of CardiologyCenter Volume Impacts Readmissions and Mortality after Congenital Cardiac Surgery
2022, Journal of PediatricsInfluence of Geographic Access on Surgical Center Readmissions After Index Congenital Heart Surgery
2021, Journal of PediatricsRisk of readmission after heart failure hospitalization in older adults with congenital heart disease
2020, International Journal of Cardiology
This work has been funded by grant G-02-MA-1137 from the Heart and Stroke Foundation of Canada and grant 6498 from the Fonds de la Recherche en Santé du Québec, Montreal, Quebec, Canada. Dr Mackie is a scientist funded by the Fonds de la Recherche en Santé du Québec, and Dr Rahme is funded by the Canadian Institutes of Health Research. Dr Pilote is a senior scientist funded by the Fonds de la Recherche en Santé du Québec and the William Dawson Professor of Medicine at McGill University. Dr Marelli was funded by the Heart and Stroke Foundation of Canada.